Evelo Biosciences Inc.
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
0.32
63080.00%
After-hours Dec 11, 2023, 06:46 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -1.23 -2.63 -5.1 -1.52 -5.28 -2.13 -3.38
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -28.11 37.06 15.66 2.16 2.08 2.04 8.17
P/FCF Ratio -1.38 -3.27 -6.42 -1.73 -5.4 -2.39 -3.33
P/OCF Ratio -1.39 -3.32 -6.53 -1.81 -6.02 -2.57 -3.66
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -10.24 6.50 1.31 0.33 0.09 0.34 1.80
Quick Ratio 4.16 4.09 3.47 7.99 16.02 10.10 6.99
Current Ratio 4.16 4.09 3.47 7.99 16.02 10.10 6.99
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -23.22 -31.95 -43.57 -82.32 -37.17 n/a n/a
Return on Equity (ROE) 22.94 -14.1 -3.07 -1.42 -0.39 -0.95 -2.41
Return on Assets (ROA) -1.78 -1.39 -1.03 -0.94 -0.34 -0.64 -0.72
Return on Capital (ROIC) -2.08 -1.64 -1.3 -1.06 -0.39 -0.69 -0.8
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a